Streptococcus pyogenes [Group A Streptococcus (GAS)] can colonize skin and mucosal membranes giving rise to carriage and localized and/or systemic infections that can range in severity (Luca-Harari et al., 2009; Fiedler et al., 2015) . Traditionally, S. pyogenes isolates were serotyped using M-and T-factor-specific anti-sera that have been replaced by M genotyping (emm typing) (Johnson et al., 2006) . The M protein is a major virulence factor of GAS and is a hair-like projection from the bacterial cell surface, where it facilitates resistance to complementmediated killing and aids in bacterial evasion of phagocytosis (Bessen et al., 2008) . The M protein is also essential for the bacterial attachment to keratinocytes that play a significant role in infections originating at the skin surface (Biswas et al., 2001) . M genotyping has made international comparisons possible and identified a worldwide perspective of strain variation. There are over 200 recorded emm types and subtypes that help in the identification of outbreaks and cluster management (CDC, 2008) . In Scotland, between 1999 and 2005, there was a rise in invasive GAS infections from 50 to 200 per year (HPS Weekly Report, 2006) , a finding consistent with observations from other European countries (Luca-Harari et al., 2009; Koutouzi et al., 2015) . This study reports on the distribution of GAS emm types and subtypes from invasive and non-invasive sites over a 4-year period and further identifies the most susceptible age/sex range for invasive disease.
GAS isolates were referred to the reference laboratory from routine Scottish microbiology laboratories between June 2011 and April 2015. All isolates were subcultured onto Columbia horse blood agar plates (Oxoid Ô ) and incubated at 37 C for 24 h in an atmosphere of 5 % CO 2 . The isolates were phenotypically identified by colony morphology, b-haemolysis and Lancefield group identification (Lancefield, 1933 ) using a Prolex Ô Strep Grouping Latex Test Kit. DNA was prepared using an achromopeptidase extraction method (Boujaafar et al., 1988) . Sequencing was performed as previously described (CDC, 2008) and sequenced on an AB 3500 xL sequencer (Molling et al., 2000) .
The sequences were manually edited using CLC Main Workbench software, and the FASTA files were uploaded to the BLAST 2.0 Server on the CDC website (CDC, 2008) . The assignation of type relies upon the 90 bases encoding the N-terminal 30 residues, but subtypes are assigned according to the exact 180 base sequences encompassing the signal peptide (10 residues) and the 50 residues of the mature M protein.
The z-test was used for statistical analysis of the data at P<0.01.
In total, 892 GAS isolates were typed by emm sequencing. Table 1 shows the distribution of the major emm types from all sites, but Table 1 . Prevalence of the top 11 S. pyogenes emm types from mucosal and cutaneous non-invasive disease sites compared to invasive sterile sites and between non-invasive mucosal and cutaneous sites emm type/subtype* Cutaneous, n (%) Eighteen emm types had insufficient isolates (<10) for statistical calculation. These included emm types 2, 9, 11, 18, 44, 58, 73, 77, 78, 81, 82, 87, 90, 102, 103, 108, 124 (Table 2) , there were statistically significant differences in sex-and age-related disease site acquisition. The major difference between the sexes related to the age when invasive disease became most prevalent. In the male population age groups (51-64 years and >65 years), there was a statistically significant increase in cases associated with invasive disease (P<0.001) compared to females when invasive disease was statistically (P<0.001) most prevalent in the >65 year age range. Other interesting observations include the prevalence of cutaneous isolates in the female 0-4 and 5-19 year age ranges changing to mucosal site acquisition in the 5-19 and 20-34 year age ranges. In the male population, mucosal acquisition was most prevalent in the 0-4 and 5-19 year age ranges with cutaneous acquisition more common in the 20-34 age range.
In conclusion, the most prevalent emm types identified were 1, 76 and 89. This is partly mirrored in other European countries, apart from emm type 76 that was linked to a single outbreak involving people who inject drugs (PWID). In 2008, there was a Europe-wide publication on emm type distribution in invasive disease covering the years [2003] [2004] , and a wide diversity of emm types (n=104) was found among clinical isolates of S. pyogenes from 11 European countries (Lamagni et al., 2008) . The 10 most predominant emm types were emm types 1, 28, 3, 89, 87, 12, 4, 83, 81 and 5 in descending order. At the national reference laboratory (England and Wales), emm strain typing on 1271 invasive GAS isolates was undertaken from October to June 2015 (PHE, 2015) . The results indicate that emm type 1 was the most common, followed by 3, 12 and 89. The isolates identified in this Scottish cohort that included both invasive and non-invasive strains were in descending order emm types 1, 76, 89, 12, 75, 28, 4 and 3. Euro-prevalent emm type 83 was identified only once in Scottish isolates. We report that emm type 1 was most significantly associated with invasive disease. A paediatric study (d'Humieres et al., 2015) showed that emm type 1 is also associated with the most lifethreatening clinical disease manifestations.
In the adult population of Europe and the USA, emm types 1 and 3 are strongly associated with invasive infections. This contrasts to Africa and Asia where emm types differ quite significantly (Steer et al., 2009; Efstratiou & Lamagni, 2016 (Zakikhany et al., 2011 , Koutozi et al., 2015 Efstratiou & Lamagni, 2016) . In 2014, Scotland saw higher than expected levels of GAS and iGAS (HPS Weekly Report, 2015) that occurred against a backdrop of increased scarlet fever notifications in the rest of the UK. The increased iGAS cases in Scotland may be attributable to a natural cycle in disease incidence, although the potential for changes in the virulence of circulating strains or increased incidence in a particular risk and age group cannot be excluded, and continued vigilance remains essential to spot changing disease patterns. 
